OVID's three largest insider shareholders as of March 23, 2026 are Pharmaceutical Co Ltd Takeda (TenPercentOwner, 7.00Mn shares), Amit Rakhit (President And Cmo, 726.82K shares), Jeffrey A Rona (Cbfo, 156.31K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Pharmaceutical Co Ltd Takeda | 0 | 7,000,000 | 09 Dec, 2025 | |
| Amit Rakhit | President And Cmo | 726,823 | 0 | 16 Jul, 2021 |
| Jeffrey A Rona | Cbfo | 156,313 | 0 | 02 Mar, 2026 |
| Margaret A. Alexander | President And Ceo | 61,750 | 0 | 02 Mar, 2026 |
| Thomas Michael Perone | General Counsel, Secretary | 28,125 | 0 | 26 Feb, 2024 |
| Jason Tardio | Chief Operating Officer | 28,125 | 0 | 26 Feb, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Feb, 2026 | Jeffrey A Rona | Common Stock | D | 8,541 | $1.45 | 88,188 | D | S |
| 23 Feb, 2026 | Margaret A. Alexander | Common Stock | D | 11,656 | $1.45 | 61,750 | D | S |
| 26 Feb, 2026 | Kevin Joseph Fitzgerald | Employee Stock Option (Right to Buy) | A | 65,000 | $0.00 | 65,000 | D | A |
| 26 Feb, 2026 | Karen Bernstein | Employee Stock Option (Right to Buy) | A | 65,000 | $0.00 | 65,000 | D | A |
| 26 Feb, 2026 | Stelios Papadopoulos | Employee Stock Option (Right to Buy) | A | 65,000 | $0.00 | 65,000 | D | A |
| 26 Feb, 2026 | Jeffrey A Rona | Common Stock | A | 68,125 | $0.00 | 156,313 | D | A |
| 26 Feb, 2026 | Margaret A. Alexander | Employee Stock Option (Right to Buy) | A | 1,435,000 | $0.00 | 1,435,000 | D | A |
| 26 Feb, 2026 | Jeffrey A Rona | Employee Stock Option (Right to Buy) | A | 408,750 | $0.00 | 408,750 | D | A |
| 04 Jan, 2026 | Margaret A. Alexander | Employee Stock Option (right to buy) | A | 890,000 | $0.00 | 890,000 | D | A |
| 08 Dec, 2025 | Pharmaceutical Co Ltd Takeda | Common Stock | A | 1,250,000 | $0.00 | 7,000,000 | I | C |
| 08 Dec, 2025 | Pharmaceutical Co Ltd Takeda | Series A Convertible Preferred Stock | D | 1,250 | $0.00 | 0 | I | C |
| 03 Mar, 2025 | Stelios Papadopoulos | Stock Option (right to buy) | A | 90,000 | $0.00 | 90,000 | D | A |
| 26 Feb, 2025 | Margaret A. Alexander | Common Stock | D | 5,279 | $0.56 | 73,406 | D | S |
| 26 Feb, 2025 | Jeffrey A Rona | Common Stock | D | 3,902 | $0.56 | 67,973 | D | S |
| 20 Feb, 2025 | Margaret A. Alexander | Common Stock | A | 43,750 | $0.00 | 78,685 | D | A |
| 20 Feb, 2025 | Jeffrey A Rona | Common Stock | A | 43,750 | $0.00 | 71,875 | D | A |
| 20 Feb, 2025 | Margaret A. Alexander | Employee Stock Option (Right to Buy) | A | 262,500 | $0.00 | 262,500 | D | A |
| 20 Feb, 2025 | Jeffrey A Rona | Employee Stock Option (Right to Buy) | A | 262,500 | $0.00 | 262,500 | D | A |
| 27 Jan, 2025 | Margaret A. Alexander | Common Stock | A | 6,810 | $0.73 | 34,935 | D | P |
| 12 Dec, 2024 | Kevin Joseph Fitzgerald | Stock Option (Right to Buy) | A | 90,000 | $0.00 | 90,000 | D | A |